Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 397 Cr.
- Current Price ₹ 322
- High / Low ₹ 342 / 162
- Stock P/E 68.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 15.7 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding has decreased over last quarter: -24.7%
- Company has a low return on equity of 13.7% over last 3 years.
- Company has high debtors of 193 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 89.29 | 70.23 | 113.70 | 124.67 | 97.39 | |
| 83.30 | 68.78 | 107.45 | 111.83 | 88.84 | |
| Operating Profit | 5.99 | 1.45 | 6.25 | 12.84 | 8.55 |
| OPM % | 6.71% | 2.06% | 5.50% | 10.30% | 8.78% |
| 0.78 | 0.26 | 0.25 | 0.44 | 0.60 | |
| Interest | 0.58 | 0.36 | 0.76 | 1.20 | 1.12 |
| Depreciation | 0.68 | 0.82 | 0.58 | 0.53 | 0.50 |
| Profit before tax | 5.51 | 0.53 | 5.16 | 11.55 | 7.53 |
| Tax % | 28.49% | -41.51% | 32.95% | 30.65% | 24.97% |
| 4.00 | 0.76 | 3.46 | 8.01 | 5.82 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.24 | 28.57 | 20.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 98% |
| TTM: | -27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 2.79 | 2.79 | 2.79 | 9.06 |
| Reserves | 30.88 | 31.63 | 35.04 | 42.75 | 48.86 | 53.00 |
| 10.24 | 7.14 | 8.50 | 5.66 | 5.75 | 3.20 | |
| 26.06 | 30.25 | 35.79 | 29.37 | 31.71 | 29.13 | |
| Total Liabilities | 67.21 | 69.05 | 82.12 | 80.57 | 89.11 | 94.39 |
| 4.20 | 4.70 | 4.38 | 4.07 | 5.11 | 4.99 | |
| CWIP | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
| Investments | 0.39 | 0.39 | 0.40 | 0.05 | 1.05 | 8.60 |
| 62.62 | 63.96 | 77.21 | 76.45 | 82.95 | 80.80 | |
| Total Assets | 67.21 | 69.05 | 82.12 | 80.57 | 89.11 | 94.39 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -8.68 | 3.88 | 3.25 | 7.98 | 2.76 | |
| 2.49 | -0.92 | -4.11 | -3.14 | -1.52 | |
| 7.40 | -3.38 | 0.74 | -3.96 | -0.94 | |
| Net Cash Flow | 1.21 | -0.42 | -0.12 | 0.87 | 0.31 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 181.05 | 221.19 | 165.29 | 143.72 | 193.39 |
| Inventory Days | 62.64 | 94.58 | 62.71 | 56.89 | 87.75 |
| Days Payable | 114.14 | 146.09 | 103.47 | 81.58 | 121.65 |
| Cash Conversion Cycle | 129.55 | 169.68 | 124.53 | 119.04 | 159.48 |
| Working Capital Days | 154.27 | 178.89 | 118.97 | 111.31 | 156.43 |
| ROCE % | 2.15% | 13.74% | 25.84% | 15.74% |
Documents
Announcements
- Closure of Trading Window 26 Mar
-
Announcement Under Regulation 30 (LODR)-Investor Presentation
22 Mar - Under Reg. 30 of the SEBI (LODR) Regulations, 2015- Investor Presentation for Analyst or Investor Meeting scheduled on 25th March, 2025 at 09:00 AM.
-
Outcome Of The Analyst / Investor Meeting Held On March 20,
2025
20 Mar - Outcome of Analyst/Investor Meeting held on March 20, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20 Mar - Schedule of Analyst/Investor Meeting on March 25, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Mar - Schedule of Analyst/Investor Meeting on March 20, 2025.
Annual reports
No data available.
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.